Abbott Laboratories Stock Swiss Exchange

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange 11:31:05 2024-02-19 am EST 5-day change 1st Jan Change
93 CHF -.--% Intraday chart for Abbott Laboratories -.--% -.--%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2024 * 41.7B 37.83B Sales 2025 * 44.74B 40.58B Capitalization 184B 167B
Net income 2024 * 5.96B 5.41B Net income 2025 * 7.18B 6.52B EV / Sales 2024 * 4.54 x
Net Debt 2024 * 5.47B 4.96B Net cash position 2025 * 640M 581M EV / Sales 2025 * 4.09 x
P/E ratio 2024 *
30.9 x
P/E ratio 2025 *
26.3 x
Employees 114,000
Yield 2024 *
2.05%
Yield 2025 *
2.19%
Free-Float 86.73%
More Fundamentals * Assessed data
Dynamic Chart
1 week
93.00
Extreme 93
93.00
1 month
93.00
Extreme 93
93.00
Current year
93.00
Extreme 93
93.00
1 year
89.00
Extreme 89
93.50
3 years
86.50
Extreme 86.5
128.00
5 years
70.00
Extreme 70
128.00
10 years
33.75
Extreme 33.75
128.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 14-12-31
Director of Finance/CFO 51 96-12-31
Chief Tech/Sci/R&D Officer - 89-12-31
Members of the board TitleAgeSince
Director/Board Member 69 17-02-15
Director/Board Member 63 17-06-28
Director/Board Member 65 11-12-08
More insiders
Date Price Change
24-05-06 93 -.--%
24-05-03 93 -.--%
24-05-02 93 -.--%
24-04-30 93 -.--%

Delayed Quote Swiss Exchange, February 19, 2024 at 11:31 am EST

More quotes
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
105.6 USD
Average target price
126.1 USD
Spread / Average Target
+19.36%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW